Susquehanna International Group’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-428
| Closed | -$4.61K | – | 6578 |
|
2023
Q4 | $4.61K | Buy |
+428
| New | +$4.61K | ﹤0.01% | 5778 |
|
2023
Q2 | – | Sell |
-427
| Closed | -$7.46K | – | 6455 |
|
2023
Q1 | $7.46K | Buy |
+427
| New | +$7.46K | ﹤0.01% | 5757 |
|
2022
Q4 | – | Sell |
-656
| Closed | -$16K | – | 6743 |
|
2022
Q3 | $16K | Buy |
656
+499
| +318% | +$12.2K | ﹤0.01% | 5764 |
|
2022
Q2 | $8K | Buy |
157
+82
| +109% | +$4.18K | ﹤0.01% | 5533 |
|
2022
Q1 | $5K | Buy |
+75
| New | +$5K | ﹤0.01% | 5613 |
|
2021
Q4 | – | Sell |
-88
| Closed | -$10K | – | 6452 |
|
2021
Q3 | $10K | Buy |
+88
| New | +$10K | ﹤0.01% | 5236 |
|
2021
Q1 | – | Sell |
-63
| Closed | -$6K | – | 5767 |
|
2020
Q4 | $6K | Buy |
+63
| New | +$6K | ﹤0.01% | 4718 |
|
2020
Q2 | – | Sell |
-984
| Closed | -$79K | – | 4932 |
|
2020
Q1 | $79K | Buy |
+984
| New | +$79K | ﹤0.01% | 4103 |
|
2019
Q4 | – | Sell |
-100
| Closed | -$11K | – | 4810 |
|
2019
Q3 | $11K | Buy |
100
+60
| +150% | +$6.6K | ﹤0.01% | 4337 |
|
2019
Q2 | $6K | Sell |
40
-9
| -18% | -$1.35K | ﹤0.01% | 4430 |
|
2019
Q1 | $8K | Buy |
+49
| New | +$8K | ﹤0.01% | 2889 |
|
2018
Q2 | – | Sell |
-4
| Closed | -$11K | – | 4687 |
|
2018
Q1 | $11K | Buy |
+4
| New | +$11K | ﹤0.01% | 3264 |
|
2017
Q3 | – | Sell |
-22
| Closed | -$107K | – | 4200 |
|
2017
Q2 | $107K | Buy |
22
+10
| +83% | +$48.6K | ﹤0.01% | 3235 |
|
2017
Q1 | $68K | Sell |
12
-7
| -37% | -$39.7K | ﹤0.01% | 3021 |
|
2016
Q4 | $128K | Buy |
+19
| New | +$128K | ﹤0.01% | 3849 |
|
2016
Q2 | – | Sell |
-48
| Closed | -$987K | – | 4044 |
|
2016
Q1 | $987K | Buy |
48
+21
| +78% | +$432K | ﹤0.01% | 2030 |
|
2015
Q4 | $536K | Buy |
+27
| New | +$536K | ﹤0.01% | 2922 |
|
2015
Q2 | – | Sell |
-12
| Closed | -$238K | – | 4739 |
|
2015
Q1 | $238K | Buy |
+12
| New | +$238K | ﹤0.01% | 3643 |
|
2014
Q2 | – | Sell |
-16
| Closed | -$360K | – | 4469 |
|
2014
Q1 | $360K | Buy |
+16
| New | +$360K | ﹤0.01% | 2859 |
|